SLCO1B1 and short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome: Further, the analysis estimated that as few as 96 to as many as 146 incident cases of SAMS (range 22.3% to 38.2% of total SAMS cases) could be averted by implementing an SLCO1B1 testing strategy within our hypothetical patient cohort.